Table 3.
Variables | MVPA minutes per day, RR (95% CI) | Active minutes per day, RR (95% CI) | Time spent away-from-home (minutes) per day, RR (95% CI) | Steps per day, RR (95% CI) | Excursions per week, RR (95% CI) |
---|---|---|---|---|---|
5-unit (dB) decrement in IVF sensitivitya | 0.82 (0.69, 0.97)* | 0.84 (0.75, 0.93)* | 0.91 (0.82, 1.03) | 0.83 (0.74, 0.93)* | 0.95 (0.86, 1.05) |
VF damagea | |||||
Normal/Mild | Reference | Reference | Reference | Reference | Reference |
Moderate | 0.87 (0.61, 1.24) | 0.93 (0.78, 1.13) | 1.08 (0.90, 1.28) | 0.98 (0.77, 1.22) | 1.23 (0.99, 1.53) |
Severe | 0.52 (0.27, 1.00)* | 0.54 (0.40, 0.72)* | 0.73 (0.51, 1.05) | 0.58 (0.41, 0.81)* | 0.95 (0.70, 1.29) |
Severity of VF damage on continuous and categorical scale were derived from different models, each containing the same covariates: age, race, sex, living arrangement, employment, education, comorbidity, polypharmacy, and cognitive function.
RR: Risk Ratio; MVPA: moderate & vigorous physical activity; VF: vision field; IVF: integrated vision field; dB: decibels; CI: confidence interval; Polypharmacy: ≥ 5 systemic prescription medications; Mini-Mental State Examination-Vision Impairment (maximum as 22).
p <0.05.